MODD Modular Medical, Inc.
Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1074871 · Fiscal year ends 03/31
Financial factors as of 2026-09-30 (2027Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY-12.9%
TTM EPS YoY71.7%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE-270.8%
ROA-212.7%
ROIC (approx.)-430.1%
Asset turnover—
Leverage & solvency
Liabilities / assets10.3%
Debt / equity0.00x
Current ratio4.46x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.92x
Accruals ratio-16.5%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-03-31 | FY20252025-03-31 | FY20242024-03-31 | FY20232023-03-31 | FY20222022-03-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | — | — | — | — | — |
| R&D expense | $19.97M | $14.70M | $12.88M | $9.06M | $7.73M |
| SG&A expense | $7.59M | $4.35M | $4.65M | $4.82M | $7.20M |
| Operating income | -$27.56M | -$19.05M | -$17.53M | -$13.88M | -$14.93M |
| Interest expense | — | — | — | — | $2.75M |
| Pretax income | -$28.24M | -$18.82M | -$17.47M | -$13.88M | -$18.63M |
| Income tax | $2,000 | $2,000 | $2,000 | $2,000 | $1,600 |
| Net income | -$28.24M | -$18.82M | -$17.47M | -$13.88M | -$18.63M |
| EBITDA | -$25.89M | -$17.98M | -$17.10M | -$13.73M | -$14.81M |
| EPS (basic) | -12.36 | -15.26 | -0.78 | -1.15 | -2.74 |
| EPS (diluted) | -12.36 | -15.26 | -0.78 | -1.15 | -2.74 |
| Weighted avg. shares (diluted) | 2.29M | 1.23M | 22.38M | 12.10M | 6.81M |
| Banking | |||||
| Net interest income | — | — | — | — | $368,920 |
| Balance sheet | |||||
| Cash & equivalents | $6.94M | $13.10M | $9.23M | $3.80M | $9.08M |
| Receivables | — | — | $142,000 | — | — |
| Current assets | $7.54M | $13.52M | $9.70M | $4.05M | $9.39M |
| PP&E, net | $6.87M | $4.45M | $2.98M | $1.72M | $235,959 |
| Total assets | $14.83M | $18.73M | $13.81M | $7.25M | $9.85M |
| Current liabilities | $1.87M | $1.26M | $1.46M | $979,000 | $969,699 |
| Total liabilities | $1.87M | $1.66M | $2.27M | $2.17M | $1.01M |
| Shareholders' equity | $12.96M | $17.08M | $11.54M | $5.08M | $8.84M |
| Shares outstanding | 4.66M | 1.79M | 32.46M | 10.95M | 10.46M |
| Cash flow statement | |||||
| Operating cash flow | -$23.75M | -$15.72M | -$13.95M | -$11.01M | -$10.26M |
| Capital expenditure | $3.93M | $2.49M | $1.70M | $1.64M | $54,764 |
| Free cash flow | -$27.68M | -$18.21M | -$15.65M | -$12.65M | -$10.31M |
| Investing cash flow | -$3.93M | -$2.49M | -$1.70M | -$1.64M | -$54,764 |
| Financing cash flow | $21.53M | $22.08M | $21.09M | $7.37M | $17.92M |
| Depreciation & amortization | $1.67M | $1.06M | $426,000 | $152,000 | $117,490 |
| Stock-based compensation | $1.78M | $2.38M | $2.70M | $2.72M | $4.03M |
Free plan shows the latest 5 periods; Pro shows all 28 🔒
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.